David Royston Selected Research

David Royston Research Topics

5	Hemorrhage 01/2022 - 08/2004
4	Myocardial Infarction 12/2006 - 08/2002
2	Stroke (Strokes) 01/2022 - 01/2004
2	Renal Insufficiency (Renal Failure) 11/2008 - 10/2006
2	Lung Injury 12/2007 - 10/2002
1	Aortic Dissection 01/2022
1	Heart Failure 12/2021
1	Ischemia 12/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2004
1	Neoplasms (Cancer) 10/2003
1	Neoplasm Micrometastasis 10/2003
1	Muscle Rigidity 02/2003
1	Unconsciousness (Loss of Consciousness) 02/2003
1	Lung Diseases (Lung Disease) 10/2002
1	Reperfusion Injury 10/2002
1	Infections 08/2002
1	Atrial Fibrillation 08/2002

6	Aprotinin (Trasylol)FDA Link 01/2022 - 08/2004
3	Troponin IIBA 12/2006 - 08/2002
2	CreatinineIBA 01/2022 - 08/2002
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2007 - 10/2002
1	Neuromuscular Blocking AgentsIBA 12/2021
1	Anesthetics (Anesthetic Agents)IBA 12/2021
1	Tranexamic Acid (AMCA)FDA Link 01/2010
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 11/2008
1	Peptides (Polypeptides)IBA 11/2008
1	Nitroglycerin (Dynamite)FDA LinkGeneric 12/2007
1	EnzymesIBA 12/2006
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2006
1	formycin diphosphate (FDP)IBA 01/2004
1	MB Form Creatine KinaseIBA 01/2004
1	Serine Proteases (Serine Protease)IBA 10/2003
1	Propofol (Diprivan)FDA LinkGeneric 02/2003
1	Pancuronium (Pavulon)FDA LinkGeneric 02/2003
1	Remifentanil (Ultiva)FDA Link 02/2003
1	Nonesterified Fatty Acids (NEFA)IBA 08/2002
1	glucose-insulin-potassium cardioplegic solutionIBA 08/2002

2	Therapeutics 11/2008 - 08/2002
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2006 - 06/2005
2	Length of Stay 08/2004 - 08/2002
1	Renal Dialysis (Hemodialysis) 11/2008
1	Lung Transplantation 12/2007
1	Blood Component Transfusion 08/2004
1	Anesthesia 02/2003